Population screening requires robust evidence-genomics is no exception

Affiliations

• ¹ Division of Genetics and Epidemiology, Institute of Cancer Research, London, Sutton, UK; The Royal Marsden NHS Foundation Trust, London, UK. Electronic address: Clare.Turnbull@icr.ac.uk.
• ² Department of Medical Genetics, University of Cambridge, Cambridge, UK; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
• ³ MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK; Oxford Centre for Genomic Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
• ⁴ Division of Evolution, Infection and Genomics, University of Manchester, Manchester, UK; Manchester University NHS Foundation Trust, Manchester, UK.
• ⁵ Department of Oncology, University of Oxford, Oxford, UK; Oxford Centre for Genomic Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
• ⁶ Charles Dent Metabolic Unit, National Hospital for Neurology, University College London Hospitals NHS Trust, London, UK.
• ⁷ Institute of Biomedical and Clinical Science, University of Exeter, Exeter, UK.
• ⁸ Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
• ⁹ Division of Genetics and Epidemiology, Institute of Cancer Research, London, Sutton, UK; The Royal Marsden NHS Foundation Trust, London, UK.
• ¹⁰ Population and Behavioural Science Division, School of Medicine, University of St Andrews, St Andrews, UK; Fulton Street Medical Centre, Glasgow, UK.
• ¹¹ Oxford Centre for Genomic Medicine, Oxford University Hospitals NHS Foundation Trust, Oxford, UK; Wellcome Centre for Human Genetics and Centre for Personalised Medicine, University of Oxford, Oxford, UK.